Text messaging approach improves weight loss in patients with nonalcoholic fatty liver disease: A randomized study

Summary

This study tested a text-messaging intervention powered by CareMessage to support weight loss in patients with nonalcoholic fatty liver disease (NAFLD). The group receiving text messages achieved significant weight loss and improved liver enzymes, demonstrating that this is an effective strategy for managing NAFLD.

Key Findings

• The intervention group lost an average of 6.9 lbs, while the control group gained 1.8 lbs.
• The texting group also saw a significant decrease in their ALT liver enzyme levels and an improvement in triglycerides.
• Patients who responded to a survey affirmed that the text messages helped with their disease management and that they would recommend the program.

Clinical Significance

This research is a significant breakthrough, proving that a text-messaging program from CareMessage can drive weight loss in patients with NAFLD—the primary treatment for this common liver disease. This approach overcomes common barriers to care by providing motivation and health information directly to patients between clinic visits.

CareMessage Product Features

Programs

Citation

Axley, P., Kodali, S., Kuo, Y.-F., et al. (2018). Text messaging approach improves weight loss in patients with nonalcoholic fatty liver disease: A randomized study. Liver International, 38(5), 924–931.